Members – observers

Associate, Pureos Bioventures  Ximing joined the Pureos Bioventures team in 2018. Prior to Pureos, he was Post-Doc at the European Molecular Biology Laboratory in Heidelberg, Germany. Ximing is currently BoD observer at Araris Biotech, Engimmune Therapeutics and Tridek-One. Ximing obtained his PhD at the European Molecular Biology Laboratory and holds

Associate, Bioqube Ventures As part of Bioqube’s investment team since 2016, Alex has been involved across the entire investment process for both portfolio investments and early stage venture creation as part of Bioqube’s dual investment model. Before the launch of BFFI, he supported the set-up and growth of multiple biotechs